Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Common Equity (2016 - 2025)

Historic Common Equity for National Healthcare (NHC) over the last 17 years, with Q3 2025 value amounting to $1.1 billion.

  • National Healthcare's Common Equity rose 723.87% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 723.87%. This contributed to the annual value of $983.2 million for FY2024, which is 798.29% up from last year.
  • Latest data reveals that National Healthcare reported Common Equity of $1.1 billion as of Q3 2025, which was up 723.87% from $1.0 billion recorded in Q2 2025.
  • In the past 5 years, National Healthcare's Common Equity registered a high of $1.1 billion during Q3 2025, and its lowest value of $810.2 million during Q1 2021.
  • Over the past 5 years, National Healthcare's median Common Equity value was $910.5 million (recorded in 2023), while the average stood at $926.6 million.
  • In the last 5 years, National Healthcare's Common Equity soared by 1871.41% in 2021 and then tumbled by 341.95% in 2023.
  • Quarter analysis of 5 years shows National Healthcare's Common Equity stood at $908.5 million in 2021, then fell by 3.41% to $877.5 million in 2022, then increased by 3.76% to $910.5 million in 2023, then increased by 7.98% to $983.2 million in 2024, then rose by 7.63% to $1.1 billion in 2025.
  • Its last three reported values are $1.1 billion in Q3 2025, $1.0 billion for Q2 2025, and $1.0 billion during Q1 2025.